# PolyPeptide Laboratories, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/polypeptide-laboratories-inc/9d05664c-4a42-45cc-81f6-ef85c356ecc1

> Inspection records and compliance data for PolyPeptide Laboratories, Inc. in Torrance, California. Access full analysis and detailed observations.

---

## Details

- Name: PolyPeptide Laboratories, Inc.
- FEI Number: 1000519239
- City: Torrance
- State: California
- Country Name: United States
- Address Line 1: 365 Maple Ave
- Zip Code: 90503
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - PolyPeptide Laboratories, Inc. - 2024-05-10](https://www.keypedia.com/records/483/polypeptide-laboratories-inc/ba06b162-f067-4036-abb1-01c2e728f3fa) — source: FDA, date: May 10, 2024
- [FDA Inspection 1246171 - PolyPeptide Laboratories, Inc. - 2024-05-10](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/7ce2e271-d893-49fa-b550-a3e1ebd8df9c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 10, 2024
- [FDA Inspection 1246171 - PolyPeptide Laboratories, Inc. - 2024-05-10](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/f50ba29e-e3b8-44a9-a050-0b7c0ebf6f77) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 10, 2024
- [EIR - PolyPeptide Laboratories, Inc. - 2021-11-19](https://www.keypedia.com/records/eir/polypeptide-laboratories-inc/19c17707-3c4a-4370-88b5-950e514b5073) — source: FDA, date: November 19, 2021
- [FDA Inspection 1159374 - PolyPeptide Laboratories, Inc. - 2021-11-19](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/af021466-df72-405e-9b69-bdd15df330cb) — classification: No Action Indicated (NAI), source: FDA, date: November 19, 2021
- [FDA Inspection 1159374 - PolyPeptide Laboratories, Inc. - 2021-11-19](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/5fd9ea50-9717-4d7a-be44-3fbd84c90649) — classification: No Action Indicated (NAI), source: FDA, date: November 19, 2021
- [EIR - PolyPeptide Laboratories, Inc. - 2019-08-30](https://www.keypedia.com/records/eir/polypeptide-laboratories-inc/2fafb6c5-c8a8-43fe-8328-27c4b5e0ba13) — source: FDA, date: August 30, 2019
- [483 - PolyPeptide Laboratories, Inc. - 2019-08-30](https://www.keypedia.com/records/483/polypeptide-laboratories-inc/b5e10f52-9c04-4a4d-8237-3a02d497c9b9) — source: FDA, date: August 30, 2019
- [FDA Inspection 1103072 - PolyPeptide Laboratories, Inc. - 2019-08-30](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/f8241a25-900b-41ee-ac9d-b8177058c42d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2019
- [FDA Inspection 1021060 - PolyPeptide Laboratories, Inc. - 2017-07-19](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/bb82abf9-badf-4502-823c-de13bd77dffb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2017
- [FDA Inspection 1021060 - PolyPeptide Laboratories, Inc. - 2017-07-19](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/ad3e102c-67c8-44cd-b715-6cb81268c9bb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2017
- [FDA Inspection 953881 - PolyPeptide Laboratories, Inc. - 2015-12-03](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/60efef6c-d3a2-437f-a8d2-33c20dac1c21) — classification: No Action Indicated (NAI), source: FDA, date: December 3, 2015
- [FDA Inspection 953881 - PolyPeptide Laboratories, Inc. - 2015-12-03](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/d741dbc5-ed38-47f1-9fa7-51aa6f144e90) — classification: No Action Indicated (NAI), source: FDA, date: December 3, 2015
- [FDA Inspection 827287 - PolyPeptide Laboratories, Inc. - 2013-04-12](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/e8d21ab3-c9ec-48c5-b7e2-1919292fbc08) — classification: No Action Indicated (NAI), source: FDA, date: April 12, 2013

## Related Companies

- [Siegfried Evionnaz SA](https://www.keypedia.com/companies/siegfried-evionnaz-sa/80827909-f3d5-4745-bc93-14f265628c39)
- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [AstraZeneca Pharmaceuticals, LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/24c4d7fa-217f-4286-8074-011be79e658f)
- [Ajinomoto Co., Inc.](https://www.keypedia.com/companies/ajinomoto-co-inc/0cddfef7-b7e4-499f-81aa-0d5e77d331d4)
- [Shandong Xinhua Pharmaceutical Company Limited](https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-company-limited/7350901d-493e-45cb-a67f-c73093cf762e)
- [Medichem, S.A.](https://www.keypedia.com/companies/medichem-sa/a0e6f1b5-f2ab-4695-a0e9-007630ef1270)
- [Cambrex Karlskoga AB](https://www.keypedia.com/companies/cambrex-karlskoga-ab/c3f2350f-a38e-4e0c-9bac-e94c0255764c)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/882d7962-58d4-4de8-9d0b-86bf2cf4773e)
- [Olon S.p.A.](https://www.keypedia.com/companies/olon-spa/7e0ac35e-0f38-43f3-8415-015a3d5c0248)

## Related Officers

- [https://www.fda.gov/media/120628/download](https://www.keypedia.com/people/santiago-gallardo-johnson/f5086b0c-c8fc-44dd-8d12-6506b9dd313f)
- [company_representative](https://www.keypedia.com/people/alexandra-limon/1a8f1851-33b8-4e50-b774-7b13bcb6fffa)
- [recipient](https://www.keypedia.com/people/timothy-f-culbreth/38e0baad-e35c-4528-bbc3-b43561c51c8d)